Keros Therapeutics, Inc.

KROS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001664710

SEC filings (opens in a new tab)

In the last 90 days, Keros Therapeutics, Inc. insiders filed 2 open-market purchases and 4 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $198.6M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Keros Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of KROS: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	99	106	+7
Shares	16.2M	16.4M	+269.1K (+1.7%)
Value	$944.5M	$893.0M	−$51.5M (−5.5%)

New holders (14)

Institutions that held Keros Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to KROS in Q1 2022
Institution	Shares	Value	% of portfolio
Walleye Capital LLC	29,046	$1.58M	0.05%
PDT Partners, LLC	17,155	$933.0K	0.08%
HighVista Strategies LLC	16,040	$872.0K	0.55%
Barclays PLC	12,720	$691.0K	0.00%
Renaissance Technologies LLC	5,300	$288.0K	0.00%
Amalgamated Bank	2,542	$138.0K	0.00%
Amalgamated Financial Corp.	2,542	$138.0K	0.00%
BIT Capital GmbH	1,700	$92.4K	0.01%
Lazard Asset Management LLC	1,237	$67.0K	0.00%
TCI Wealth Advisors, Inc.	76	$4.00K	0.00%
Parallel Advisors, LLC	44	$2.00K	0.00%
Signaturefd, LLC	13	$1.00K	0.00%
Lindbrook Capital, LLC	17	$1.00K	0.00%
Covestor Ltd	5	$0	0.00%

Sold out (7)

Institutions that held Keros Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of KROS in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Darwin Global Management, Ltd.	111,500	$6.52M
Point72 Asset Management, L.P.	63,028	$3.69M
Parametric Portfolio Associates LLC	3,981	$233.0K
Arizona State Retirement System	3,455	$202.0K
Cubist Systematic Strategies, LLC	214	$13.0K
Point72 Hong Kong Ltd	198	$12.0K
Quantbot Technologies LP	200	$11.0K